MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-TS-02-0001917
Diagnostic Biosystems USA Private Limited - healthcare in Secunderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹5.77 Cr
▲ 40% YoY
Net profit · FY 2025
₹5.34 Lakh
Net margin 0.9%
EBITDA · FY 2025
₹9.98 Lakh
EBITDA margin 1.7%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Diagnostic Biosystems USA Private Limited
Data last updated:
Diagnostic Biosystems USA Private Limited is a foreign private limited company based in Secunderabad, Telangana, India, a subsidiary of Diagnostic Biosystems Inc. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 31 July 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U52609TG2019FTC134481. Its GSTIN is 36AAHCD3645E1ZS (Telangana).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Bipin Chandra Gupta and Ananda Kumar Meesala.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at # 9 – 1 – 87 & 9 – 1 – 119/1 612 Eden Square St. John'S Road, Secunderabad, Telangana, India – 500003.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.77 Cr, a growth of 40% compared to the previous year. For the same year it recorded a net profit of ₹5.34 Lakh (net margin 0.9%) and EBITDA of ₹9.98 Lakh (EBITDA margin 1.7%). Revenue has grown at a compounded annual rate (CAGR) of 34% over three years and 121% over five years.
The company is associated with 1 brand: Diagnostic BioSystems.
Diagnostic Biosystems USA Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0001917). For more details, the company can be reached via its website dbiosys.com.
Company details
CIN U52609TG2019FTC134481
Registration Number 134481
Incorporation Date 31 July 2019
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Diagnostic Biosystems Inc
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0001917
Recognitions & Rankings of Diagnostic Biosystems USA
Contact details
Diagnostic Biosystems USA Private Limited's registered office is in Secunderabad, Telangana. Its website is dbiosys.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address# 9 – 1 – 87 & 9 – 1 – 119/1 612 Eden Square St. John'S Road, Secunderabad, Telangana, India – 500003
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Diagnostic Biosystems USA Private Limited, buy the company report.
Comprehensive company report
Diagnostic Biosystems USA Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Diagnostic Biosystems USA operates one associated brand: Diagnostic BioSystems. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Diagnostic BioSystems is engaged in providing immunohistochemistry solutions. | dbiosys.com |
Business activity
The main business activity of Diagnostic Biosystems USA is hospital and medical care. In detail, this covers hospital activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q1 | Hospital activities |
To see the full business activity and turnover split of Diagnostic Biosystems USA Private Limited, buy the company report.
Financials of Diagnostic Biosystems USA Private Limited
FY 2024 filings availableDiagnostic Biosystems USA Private Limited reported revenue of ₹5.77 Cr (up 40% YoY) for FY 2025.
Revenue · FY 2025
₹5.77 Cr ▲ 40%
Net profit · FY 2025
₹5.34 Lakh margin 0.9%
EBITDA · FY 2025
₹9.98 Lakh margin 1.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 40%
3 years · compounded
▲ 34%
5 years · compounded
▲ 121%
EBITDA CAGR growth
1 year
▲ 111%
3 years · compounded
▲ 28%
5 years · compounded
▲ 17%
Revenue has grown at a compounded annual rate (CAGR) of 121% over five years, including 40% growth in the latest year. EBITDA rose 111% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.98 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.34 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.7% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Diagnostic Biosystems USA Private Limited, buy the company report.
Board of directors of Diagnostic Biosystems USA Private Limited
Diagnostic Biosystems USA has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bipin Chandra Gupta | Director | 31 Jul 2019 | 7 Years 3 Months | Current |
| Ananda Kumar Meesala | Director | 31 Jul 2019 | 7 Years 3 Months | Current |
Auditor
Diagnostic Biosystems USA Private Limited is audited by MHA & ASSOCIATES LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MHA & ASSOCIATES LLP | FY 2023 | 0S200133 |
Shareholding
The shareholding of Diagnostic Biosystems USA Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Diagnostic Biosystems USA Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Diagnostic Biosystems USA Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Diagnostic Biosystems USA Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Diagnostic Biosystems USA has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAHCD3645E1ZS | Telangana | Active | 06 Aug 2019 |
To see the full GST registrations and return filing status of Diagnostic Biosystems USA Private Limited, buy the company report.
Recent activity
Diagnostic Biosystems USA Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Ananda Kumar Meesala was appointed as Director on 31 Jul 2019.
AGM
Diagnostic Biosystems Usa Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Diagnostic Biosystems Usa Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Appointed
Ananda Kumar Meesala was appointed as Director.
Appointed
Bipin Chandra Gupta was appointed as Director.
Incorporation
31 Jul 2019
Diagnostic Biosystems Usa Private Limited was registered on 31 Jul 2019 with Roc Hyderabad & aged 7 years 3 months as per MCA records.
Frequently asked questions
Diagnostic Biosystems USA is an active foreign private limited company based in Secunderabad, Telangana, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 31 July 2019 (7+ years old) and is registered under CIN U52609TG2019FTC134481.
Diagnostic Biosystems USA has 2 current directors:
- Bipin Chandra Gupta - Director
- Ananda Kumar Meesala - Director
The latest financial statements of Diagnostic Biosystems USA on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Diagnostic Biosystems USA is 36AAHCD3645E1ZS, registered in Telangana.
The CIN (Corporate Identification Number) of Diagnostic Biosystems USA is U52609TG2019FTC134481. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Diagnostic Biosystems USA was incorporated on 31 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
Ananda Kumar Meesala was appointed as Director on 31 Jul 2019. Bipin Chandra Gupta was appointed as Director on 31 Jul 2019.
Yes, Diagnostic Biosystems USA is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0001917).
Diagnostic Biosystems USA can be reached through the website dbiosys.com. Its registered office is in Secunderabad, Telangana, India.
The registered office of Diagnostic Biosystems USA is at # 9 – 1 – 87 & 9 – 1 – 1191 612 Eden Square St. JohnS Road, Secunderabad, Telangana, India – 500003.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages